Rebecca Marchant
Papers
2
Total Citations
17
H-Index
2
About
Dr. Rebecca Marchant is a health services researcher whose work sits at the critical intersection of urologic oncology and healthcare economics. Her primary research focus is the comparative cost-effectiveness of minimally invasive treatments for small renal masses, a rapidly growing clinical challenge. Dr. Marchant’s major contribution lies in providing rigorous, data-driven evidence to guide clinical decision-making in an era of rising healthcare costs. Her landmark 2022 study, which directly compared the cost-effectiveness of percutaneous microwave ablation (MWA) against robotic-assisted partial nephrectomy (RA-PN), has become a foundational reference in the field, accumulating 11 citations. This work was preceded by a detailed 2021 analysis of perioperative costs, which established a robust methodology for comparing these two competing technologies. By quantifying the economic implications of these surgical choices, Dr. Marchant’s research empowers clinicians and hospital administrators to optimize patient care without sacrificing financial sustainability. Her work is essential reading for anyone interested in value-based care in surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2